Hogan Lovells (Washington)

Kenneth W. Field

Hogan Lovells (Washington)
Antitrust Partner, Health Care Antitrust Practice Leader

Ken Field is Antitrust Partner and Health Care Antitrust Practice Leader at Hogan Lovells’ Washington, D.C. office. Ken advises clients on all aspects of antitrust and competition law and focuses on representing clients before the U.S. Department of Justice, the Federal Trade Commission, and state antitrust enforcement authorities. He has a broad range of experience in health care, mergers and acquisitions, government investigations, litigation, counseling, and compliance programs and has represented clients from numerous industries, including health care, retail, consumer products, telecommunications, transportation, energy, and more. Field earned his J.D. and MBA from the Georgetown University Law Center and a B.A. in Political Science from the University of California, San Diego. Before joining Hogan Lovells, he worked at Jones Day as an antitrust partner and co-chair of the firm’s global Health Care Practice. Previously, he worked at the Bureau of Competition of the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice.


Linked authors

Hogan Lovells (Madrid)
Hogan Lovells (London)
Hogan Lovells (London)
Hogan Lovells (Washington)
Hogan Lovells (Washington)


1096 Bulletin

Catherine E. Livingston, James Lenahan Poth, Aimee DeFilippo, Kenneth W. Field, Michael A. Gleason, Lisa Han, David Kiernan, Margaret A. Ward The US Congress passes the Competitive Health Insurance Reform Act limiting the antitrust exemption available to companies under the McCarran-Ferguson Act


In Short The Development: Congress unanimously passed and before leaving office, President Trump signed into law, the Competitive Health Insurance Reform Act ("CHIRA"). CHIRA limits application of the McCarran-Ferguson Act, an exemption from the federal antitrust laws, as it relates to the (...)

Kenneth W. Field, Aimee DeFilippo, Kristie Xian, Michael A. Gleason The US Court of Appeals for the Eighth Circuit upholds an injunction against a proposed acquisition of a hospital on the grounds that it would lead to near-monopolisation in four different markets (Sanford Health / Sanford Bismarck / Mid Dakota Clinic)


In a decision that extends the FTC’s winning streak in the courts of appeals in healthcare provider merger cases, the Eighth Circuit affirmed the Federal Trade Commission’s ("FTC") bid to enjoin Sanford Health’s acquisition of Mid Dakota Clinic ("MDC"). This decision follows almost three years of (...)

Send a message